Structure

Physi-Chem Properties

Molecular Weight:  496.28
Volume:  521.576
LogP:  3.491
LogD:  2.987
LogS:  -4.455
# Rotatable Bonds:  2
TPSA:  100.9
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.297
Synthetic Accessibility Score:  4.96
Fsp3:  0.7
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.22
MDCK Permeability:  1.8639177142176777e-05
Pgp-inhibitor:  0.608
Pgp-substrate:  0.018
Human Intestinal Absorption (HIA):  0.018
20% Bioavailability (F20%):  0.245
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.358
Plasma Protein Binding (PPB):  93.51119232177734%
Volume Distribution (VD):  0.915
Pgp-substrate:  9.776090621948242%

ADMET: Metabolism

CYP1A2-inhibitor:  0.038
CYP1A2-substrate:  0.939
CYP2C19-inhibitor:  0.059
CYP2C19-substrate:  0.763
CYP2C9-inhibitor:  0.226
CYP2C9-substrate:  0.309
CYP2D6-inhibitor:  0.215
CYP2D6-substrate:  0.126
CYP3A4-inhibitor:  0.869
CYP3A4-substrate:  0.834

ADMET: Excretion

Clearance (CL):  15.075
Half-life (T1/2):  0.378

ADMET: Toxicity

hERG Blockers:  0.005
Human Hepatotoxicity (H-HT):  0.313
Drug-inuced Liver Injury (DILI):  0.136
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.194
Maximum Recommended Daily Dose:  0.83
Skin Sensitization:  0.09
Carcinogencity:  0.58
Eye Corrosion:  0.004
Eye Irritation:  0.34
Respiratory Toxicity:  0.889

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470038

Natural Product ID:  NPC470038
Common Name*:   Blepharodol
IUPAC Name:   methyl (2S,4aS,6aR,6aR,14aS,14bR)-10,11-dihydroxy-2,4a,6a,6a,9,14a-hexamethyl-3,8-dioxo-4,5,6,6b,7,13,14,14b-octahydro-1H-picene-2-carboxylate
Synonyms:   Blepharodol
Standard InCHIKey:  IWTGNLXWDMHZOI-QYOTWRPRSA-N
Standard InCHI:  InChI=1S/C30H40O6/c1-16-23-17(12-19(32)24(16)34)27(3)9-11-30(6)21-14-28(4,25(35)36-7)22(33)15-26(21,2)8-10-29(30,5)20(27)13-18(23)31/h12,20-21,32,34H,8-11,13-15H2,1-7H3/t20?,21-,26+,27+,28+,29-,30+/m1/s1
SMILES:  COC(=O)[C@@]1(C)C[C@@H]2[C@@](CC1=O)(C)CC[C@]1([C@@]2(C)CC[C@@]2(C1CC(=O)c1c2cc(O)c(c1C)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1651348
PubChem CID:   53326085
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25224 Maytenus retusa Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[21090801]
NPO25224 Maytenus retusa Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens Inhibition = 7.0 % PMID[521356]
NPT83 Cell Line MCF7 Homo sapiens Inhibition = 8.0 % PMID[521356]
NPT83 Cell Line MCF7 Homo sapiens Inhibition = 15.0 % PMID[521356]
NPT116 Cell Line HL-60 Homo sapiens Inhibition = 100.0 % PMID[521356]
NPT116 Cell Line HL-60 Homo sapiens Inhibition = 79.0 % PMID[521356]
NPT116 Cell Line HL-60 Homo sapiens Inhibition = 69.0 % PMID[521356]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470038 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.965 High Similarity NPC470037
0.964 High Similarity NPC184935
0.9496 High Similarity NPC470035
0.942 High Similarity NPC49911
0.9306 High Similarity NPC10842
0.9281 High Similarity NPC277559
0.8993 High Similarity NPC476282
0.8897 High Similarity NPC199936
0.8889 High Similarity NPC185617
0.8849 High Similarity NPC243305
0.8776 High Similarity NPC75295
0.8723 High Similarity NPC111845
0.8681 High Similarity NPC469681
0.8681 High Similarity NPC469680
0.8681 High Similarity NPC471974
0.8671 High Similarity NPC7464
0.8667 High Similarity NPC142654
0.8649 High Similarity NPC258856
0.8601 High Similarity NPC103082
0.8601 High Similarity NPC43353
0.8601 High Similarity NPC153088
0.8592 High Similarity NPC138472
0.8562 High Similarity NPC471853
0.8552 High Similarity NPC473479
0.8552 High Similarity NPC477849
0.8552 High Similarity NPC165191
0.8552 High Similarity NPC469857
0.8552 High Similarity NPC157284
0.8552 High Similarity NPC51531
0.8552 High Similarity NPC46242
0.8552 High Similarity NPC5014
0.8552 High Similarity NPC289358
0.8552 High Similarity NPC42384
0.8552 High Similarity NPC245760
0.8552 High Similarity NPC28592
0.8552 High Similarity NPC114333
0.8552 High Similarity NPC297797
0.8552 High Similarity NPC473779
0.8552 High Similarity NPC149773
0.8552 High Similarity NPC23667
0.8552 High Similarity NPC91887
0.8552 High Similarity NPC50615
0.8531 High Similarity NPC293454
0.8493 Intermediate Similarity NPC294330
0.8456 Intermediate Similarity NPC8493
0.8456 Intermediate Similarity NPC469375
0.8456 Intermediate Similarity NPC144247
0.8456 Intermediate Similarity NPC294679
0.8456 Intermediate Similarity NPC145301
0.8446 Intermediate Similarity NPC469447
0.8446 Intermediate Similarity NPC30846
0.8446 Intermediate Similarity NPC248068
0.8446 Intermediate Similarity NPC469855
0.8446 Intermediate Similarity NPC477873
0.8446 Intermediate Similarity NPC471971
0.8446 Intermediate Similarity NPC471972
0.8435 Intermediate Similarity NPC476534
0.8435 Intermediate Similarity NPC473527
0.8431 Intermediate Similarity NPC124842
0.8425 Intermediate Similarity NPC230811
0.8356 Intermediate Similarity NPC471152
0.8355 Intermediate Similarity NPC264229
0.8355 Intermediate Similarity NPC46549
0.8345 Intermediate Similarity NPC258502
0.8344 Intermediate Similarity NPC471970
0.8344 Intermediate Similarity NPC143685
0.8344 Intermediate Similarity NPC273798
0.8333 Intermediate Similarity NPC309169
0.8333 Intermediate Similarity NPC469854
0.8333 Intermediate Similarity NPC4170
0.8333 Intermediate Similarity NPC53520
0.8333 Intermediate Similarity NPC196941
0.8333 Intermediate Similarity NPC294226
0.8333 Intermediate Similarity NPC469856
0.8323 Intermediate Similarity NPC62051
0.8322 Intermediate Similarity NPC291001
0.8299 Intermediate Similarity NPC416
0.8299 Intermediate Similarity NPC61398
0.8298 Intermediate Similarity NPC69424
0.8298 Intermediate Similarity NPC176130
0.8298 Intermediate Similarity NPC78364
0.8298 Intermediate Similarity NPC84672
0.8289 Intermediate Similarity NPC52692
0.8288 Intermediate Similarity NPC472308
0.8278 Intermediate Similarity NPC8102
0.8278 Intermediate Similarity NPC66894
0.8276 Intermediate Similarity NPC202225
0.8252 Intermediate Similarity NPC108129
0.8239 Intermediate Similarity NPC266365
0.8235 Intermediate Similarity NPC132810
0.8224 Intermediate Similarity NPC474991
0.8217 Intermediate Similarity NPC471968
0.8212 Intermediate Similarity NPC126707
0.82 Intermediate Similarity NPC85310
0.8194 Intermediate Similarity NPC18798
0.8194 Intermediate Similarity NPC471851
0.8182 Intermediate Similarity NPC276238
0.8182 Intermediate Similarity NPC303910
0.8182 Intermediate Similarity NPC237441
0.817 Intermediate Similarity NPC470757
0.8169 Intermediate Similarity NPC72667
0.8158 Intermediate Similarity NPC68441
0.8158 Intermediate Similarity NPC84786
0.8153 Intermediate Similarity NPC472807
0.8133 Intermediate Similarity NPC2681
0.8133 Intermediate Similarity NPC92079
0.8133 Intermediate Similarity NPC272907
0.8129 Intermediate Similarity NPC473579
0.8129 Intermediate Similarity NPC475454
0.8129 Intermediate Similarity NPC48949
0.8129 Intermediate Similarity NPC473680
0.8129 Intermediate Similarity NPC475311
0.8125 Intermediate Similarity NPC117609
0.8113 Intermediate Similarity NPC326084
0.8112 Intermediate Similarity NPC234175
0.8112 Intermediate Similarity NPC229894
0.811 Intermediate Similarity NPC472803
0.8108 Intermediate Similarity NPC475957
0.8108 Intermediate Similarity NPC147418
0.8105 Intermediate Similarity NPC246229
0.8105 Intermediate Similarity NPC191899
0.8105 Intermediate Similarity NPC476535
0.8105 Intermediate Similarity NPC58752
0.8099 Intermediate Similarity NPC254492
0.8095 Intermediate Similarity NPC72918
0.8095 Intermediate Similarity NPC477596
0.8089 Intermediate Similarity NPC305710
0.8085 Intermediate Similarity NPC199273
0.8082 Intermediate Similarity NPC49742
0.8082 Intermediate Similarity NPC474715
0.8082 Intermediate Similarity NPC475457
0.8082 Intermediate Similarity NPC475346
0.8082 Intermediate Similarity NPC78307
0.8082 Intermediate Similarity NPC18982
0.8082 Intermediate Similarity NPC475627
0.8082 Intermediate Similarity NPC477139
0.8079 Intermediate Similarity NPC239136
0.8079 Intermediate Similarity NPC169214
0.8079 Intermediate Similarity NPC141817
0.8079 Intermediate Similarity NPC11314
0.8079 Intermediate Similarity NPC192597
0.8079 Intermediate Similarity NPC19631
0.8079 Intermediate Similarity NPC176030
0.8079 Intermediate Similarity NPC229218
0.8077 Intermediate Similarity NPC35
0.8077 Intermediate Similarity NPC144283
0.8075 Intermediate Similarity NPC315772
0.8067 Intermediate Similarity NPC3218
0.8067 Intermediate Similarity NPC315578
0.8067 Intermediate Similarity NPC304110
0.8067 Intermediate Similarity NPC225243
0.8067 Intermediate Similarity NPC27518
0.8065 Intermediate Similarity NPC474310
0.8065 Intermediate Similarity NPC327962
0.8065 Intermediate Similarity NPC303989
0.8063 Intermediate Similarity NPC475449
0.8056 Intermediate Similarity NPC171460
0.8056 Intermediate Similarity NPC117899
0.8054 Intermediate Similarity NPC206207
0.8054 Intermediate Similarity NPC4214
0.8054 Intermediate Similarity NPC141368
0.8054 Intermediate Similarity NPC182249
0.8052 Intermediate Similarity NPC127046
0.8052 Intermediate Similarity NPC5568
0.805 Intermediate Similarity NPC317580
0.8039 Intermediate Similarity NPC160777
0.8039 Intermediate Similarity NPC73416
0.8039 Intermediate Similarity NPC12402
0.8038 Intermediate Similarity NPC318270
0.8037 Intermediate Similarity NPC200726
0.8027 Intermediate Similarity NPC472262
0.8027 Intermediate Similarity NPC161964
0.8027 Intermediate Similarity NPC287604
0.8027 Intermediate Similarity NPC477594
0.8027 Intermediate Similarity NPC204582
0.8026 Intermediate Similarity NPC474203
0.8026 Intermediate Similarity NPC295712
0.8026 Intermediate Similarity NPC174905
0.8026 Intermediate Similarity NPC313047
0.8026 Intermediate Similarity NPC25491
0.8026 Intermediate Similarity NPC451542
0.8026 Intermediate Similarity NPC100242
0.8026 Intermediate Similarity NPC293545
0.8026 Intermediate Similarity NPC66593
0.8025 Intermediate Similarity NPC164912
0.8014 Intermediate Similarity NPC198014
0.8013 Intermediate Similarity NPC280295
0.8013 Intermediate Similarity NPC118033
0.8013 Intermediate Similarity NPC315520
0.8013 Intermediate Similarity NPC472904
0.8013 Intermediate Similarity NPC205766
0.8 Intermediate Similarity NPC155192
0.8 Intermediate Similarity NPC249340
0.8 Intermediate Similarity NPC162935
0.8 Intermediate Similarity NPC473591
0.8 Intermediate Similarity NPC26924
0.8 Intermediate Similarity NPC271494
0.8 Intermediate Similarity NPC471907
0.7988 Intermediate Similarity NPC472622
0.7988 Intermediate Similarity NPC177362

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470038 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8503 High Similarity NPD8166 Discontinued
0.8158 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD7458 Discontinued
0.7895 Intermediate Similarity NPD7003 Approved
0.7857 Intermediate Similarity NPD7390 Discontinued
0.7818 Intermediate Similarity NPD7473 Discontinued
0.7748 Intermediate Similarity NPD5404 Approved
0.7748 Intermediate Similarity NPD5406 Approved
0.7748 Intermediate Similarity NPD5408 Approved
0.7748 Intermediate Similarity NPD5405 Approved
0.7688 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7682 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD6232 Discontinued
0.7534 Intermediate Similarity NPD1470 Approved
0.7533 Intermediate Similarity NPD943 Approved
0.75 Intermediate Similarity NPD1201 Approved
0.7483 Intermediate Similarity NPD3019 Approved
0.7467 Intermediate Similarity NPD6663 Approved
0.7432 Intermediate Similarity NPD5736 Approved
0.7361 Intermediate Similarity NPD2932 Approved
0.7342 Intermediate Similarity NPD3300 Phase 2
0.7338 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD2935 Discontinued
0.7273 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD8150 Discontinued
0.7262 Intermediate Similarity NPD6959 Discontinued
0.7244 Intermediate Similarity NPD2346 Discontinued
0.7229 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD2799 Discontinued
0.7212 Intermediate Similarity NPD7819 Suspended
0.7205 Intermediate Similarity NPD6273 Approved
0.72 Intermediate Similarity NPD8312 Approved
0.72 Intermediate Similarity NPD8313 Approved
0.7197 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD3226 Approved
0.7143 Intermediate Similarity NPD2533 Approved
0.7143 Intermediate Similarity NPD2534 Approved
0.7143 Intermediate Similarity NPD2532 Approved
0.7143 Intermediate Similarity NPD230 Phase 1
0.7115 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD5844 Phase 1
0.7108 Intermediate Similarity NPD1465 Phase 2
0.7108 Intermediate Similarity NPD2801 Approved
0.7095 Intermediate Similarity NPD9269 Phase 2
0.7083 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD3026 Approved
0.7075 Intermediate Similarity NPD3023 Approved
0.7067 Intermediate Similarity NPD1164 Approved
0.7063 Intermediate Similarity NPD5951 Approved
0.7059 Intermediate Similarity NPD3764 Approved
0.7055 Intermediate Similarity NPD3025 Approved
0.7055 Intermediate Similarity NPD3024 Approved
0.7048 Intermediate Similarity NPD1934 Approved
0.7044 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6166 Phase 2
0.7035 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1283 Approved
0.7 Intermediate Similarity NPD4628 Phase 3
0.6987 Remote Similarity NPD6651 Approved
0.6982 Remote Similarity NPD7075 Discontinued
0.6975 Remote Similarity NPD1511 Approved
0.6971 Remote Similarity NPD7074 Phase 3
0.697 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6964 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6959 Remote Similarity NPD8127 Discontinued
0.6957 Remote Similarity NPD6190 Approved
0.6954 Remote Similarity NPD7228 Approved
0.695 Remote Similarity NPD3021 Approved
0.695 Remote Similarity NPD3022 Approved
0.6941 Remote Similarity NPD6234 Discontinued
0.6936 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3882 Suspended
0.6923 Remote Similarity NPD7768 Phase 2
0.6914 Remote Similarity NPD7054 Approved
0.6905 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6903 Remote Similarity NPD8032 Phase 2
0.6892 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6892 Remote Similarity NPD4626 Approved
0.689 Remote Similarity NPD1512 Approved
0.6886 Remote Similarity NPD7411 Suspended
0.6883 Remote Similarity NPD7008 Discontinued
0.6883 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7472 Approved
0.6871 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6867 Remote Similarity NPD3972 Approved
0.6864 Remote Similarity NPD3817 Phase 2
0.6863 Remote Similarity NPD9494 Approved
0.6859 Remote Similarity NPD3620 Phase 2
0.6859 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6859 Remote Similarity NPD4060 Phase 1
0.6845 Remote Similarity NPD37 Approved
0.6839 Remote Similarity NPD2313 Discontinued
0.6832 Remote Similarity NPD2800 Approved
0.6829 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6826 Remote Similarity NPD4380 Phase 2
0.6826 Remote Similarity NPD7028 Phase 2
0.6826 Remote Similarity NPD6599 Discontinued
0.6824 Remote Similarity NPD9268 Approved
0.6823 Remote Similarity NPD8151 Discontinued
0.6821 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6816 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6813 Remote Similarity NPD2344 Approved
0.681 Remote Similarity NPD7236 Approved
0.6802 Remote Similarity NPD5494 Approved
0.68 Remote Similarity NPD3092 Approved
0.68 Remote Similarity NPD1281 Approved
0.6798 Remote Similarity NPD7251 Discontinued
0.6797 Remote Similarity NPD2798 Approved
0.679 Remote Similarity NPD3750 Approved
0.679 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6789 Remote Similarity NPD8320 Phase 1
0.6789 Remote Similarity NPD8319 Approved
0.6784 Remote Similarity NPD3749 Approved
0.6779 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6761 Remote Similarity NPD3818 Discontinued
0.6761 Remote Similarity NPD6831 Clinical (unspecified phase)
0.676 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6757 Remote Similarity NPD3091 Approved
0.675 Remote Similarity NPD6099 Approved
0.675 Remote Similarity NPD6100 Approved
0.6746 Remote Similarity NPD6801 Discontinued
0.6742 Remote Similarity NPD6797 Phase 2
0.6737 Remote Similarity NPD7435 Discontinued
0.6735 Remote Similarity NPD9493 Approved
0.6732 Remote Similarity NPD3094 Phase 2
0.6727 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6727 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6725 Remote Similarity NPD4966 Approved
0.6725 Remote Similarity NPD4965 Approved
0.6725 Remote Similarity NPD4967 Phase 2
0.6709 Remote Similarity NPD447 Suspended
0.6703 Remote Similarity NPD8434 Phase 2
0.6687 Remote Similarity NPD1510 Phase 2
0.6687 Remote Similarity NPD4110 Phase 3
0.6687 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6873 Phase 2
0.6667 Remote Similarity NPD7095 Approved
0.6667 Remote Similarity NPD7808 Phase 3
0.6667 Remote Similarity NPD1607 Approved
0.6667 Remote Similarity NPD7177 Discontinued
0.6667 Remote Similarity NPD6535 Approved
0.6667 Remote Similarity NPD6534 Approved
0.6667 Remote Similarity NPD3455 Phase 2
0.6649 Remote Similarity NPD7699 Phase 2
0.6649 Remote Similarity NPD7700 Phase 2
0.6647 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6646 Remote Similarity NPD825 Approved
0.6646 Remote Similarity NPD1240 Approved
0.6646 Remote Similarity NPD2979 Phase 3
0.6646 Remote Similarity NPD2309 Approved
0.6646 Remote Similarity NPD826 Approved
0.6644 Remote Similarity NPD9545 Approved
0.6629 Remote Similarity NPD5710 Approved
0.6629 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6629 Remote Similarity NPD5711 Approved
0.6627 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6624 Remote Similarity NPD3268 Approved
0.6613 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6613 Remote Similarity NPD6212 Phase 3
0.6613 Remote Similarity NPD6213 Phase 3
0.6611 Remote Similarity NPD7685 Pre-registration
0.6607 Remote Similarity NPD7239 Suspended
0.6605 Remote Similarity NPD7266 Discontinued
0.6604 Remote Similarity NPD6355 Discontinued
0.66 Remote Similarity NPD1651 Approved
0.66 Remote Similarity NPD5691 Approved
0.6599 Remote Similarity NPD2629 Approved
0.6582 Remote Similarity NPD7961 Discontinued
0.6581 Remote Similarity NPD257 Approved
0.6581 Remote Similarity NPD258 Approved
0.6579 Remote Similarity NPD6779 Approved
0.6579 Remote Similarity NPD6781 Approved
0.6579 Remote Similarity NPD6780 Approved
0.6579 Remote Similarity NPD6782 Approved
0.6579 Remote Similarity NPD6776 Approved
0.6579 Remote Similarity NPD6778 Approved
0.6579 Remote Similarity NPD6777 Approved
0.6575 Remote Similarity NPD4954 Approved
0.6575 Remote Similarity NPD36 Approved
0.6575 Remote Similarity NPD7635 Approved
0.6575 Remote Similarity NPD4955 Approved
0.6575 Remote Similarity NPD5028 Approved
0.6575 Remote Similarity NPD5026 Approved
0.6575 Remote Similarity NPD5034 Approved
0.6573 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7199 Phase 2
0.6566 Remote Similarity NPD6799 Approved
0.6558 Remote Similarity NPD1876 Approved
0.6556 Remote Similarity NPD4059 Approved
0.6556 Remote Similarity NPD3095 Discontinued
0.6545 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6543 Remote Similarity NPD2438 Suspended
0.6541 Remote Similarity NPD4140 Approved
0.6531 Remote Similarity NPD7875 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data